Companies:
50,180
Total Market Cap:
139205622635062.81
Global Rank
#16319
Country Rank
#233
Market Cap
373.46 M
Price
14.64
Change (%)
1.56%
Volume
47,220
Medios AG's latest marketcap:
373.46 M
As of 08/02/2025, Medios AG's market capitalization has reached $373.46 M. According to our data, Medios AG is the 16319th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 373.46 M |
| Revenue (ttm) | 2.21 B |
| Net Income (ttm) | 17.31 M |
| Shares Out | 25.51 M |
| EPS (ttm) | 0.68 |
| Forward PE | 11.10 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/13/2025 |
Market Cap Chart
Data Updated: 08/02/2025
Medios AG's yearly market capitalization.
Medios AG has seen its market value grow from €96.89 M to €322.39 M since 2016, representing a total increase of 232.74% and an annual compound growth rate (CAGR) of 15.02%.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | €322.39 M | $373.46 M | -2.89% | 16319 |
| 12/30/2024 | €337.24 M | $349.12 M | -10.68% | 15397 |
| 12/29/2023 | €377.56 M | $416.73 M | -5.71% | 14218 |
| 12/30/2022 | €400.43 M | $428.56 M | -49.14% | 13238 |
| 12/30/2021 | €787.29 M | $894.83 M | 30.87% | 9947 |
| 12/30/2020 | €601.58 M | $734.76 M | 56.46% | 9506 |
| 12/30/2019 | €384.49 M | $431.12 M | 108.44% | 10779 |
| 12/28/2018 | €184.46 M | $211.51 M | -30.95% | 13641 |
| 12/29/2017 | €267.13 M | $320.4 M | 175.71% | 12603 |
| 12/30/2016 | €96.89 M | $101.89 M | 15874 |
Company Profile
About Medios AG
Medios AG, along with its subsidiaries, specializes in supplying specialty pharmaceutical drugs, primarily serving the German market.
Business Segments
The company operates through two key segments:
- Pharmaceutical Supply: Provides products targeting oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.
- Patient-Specific Therapies: Manufactures customized medications for patients on behalf of pharmacies, including:
- Cytostatic infusion preparations
- Antibody therapies
- Virostatic and antibiotic medications
- Parenteral nutrition solutions
- Investigational medicinal products
Company Background
Founded in 2016, Medios AG is headquartered in Berlin, Germany.
Frequently Asked Questions
-
What is Medios AG's (ETR-ILM1) current market cap?As of 08/02/2025, Medios AG (including the parent company, if applicable) has an estimated market capitalization of $373.46 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Medios AG (ETR-ILM1) rank globally by market cap?Medios AG global market capitalization ranking is approximately 16319 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.